Breast and lung cancers in two cyclosporin-A-treated psoriatic women

Dermatology

Volumn 196, Issue 4, 1998, Pages 450-452

  Paquet, P ^a,b   Pierard G E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

Breast cancer; Cyclosporin A; Lung cancer; Psoriasis

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; FEMALE; HUMAN; LONG TERM CARE; LUNG CANCER; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PSORIASIS; SKIN INFLAMMATION;

ADULT; BREAST NEOPLASMS; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG NEOPLASMS; MIDDLE AGED; PSORIASIS;

EID: 2642596048     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017946     Document Type: Article

References (26)

1. Gupta A, Brown MD, Ellis CM, Rocher LL, Fisher GJ, Baadsgaard O, Cooper KD, Voorhees JJ: Cyclosporine in dermatology. J Am AcadDermatol I989;21:1245-1256.
2. Kurki PT: Safety aspects of the long-term cyclosporin A therapy. Scand J Rheumatol 1992; 21(suppl 95):35-38.
3. Valdimarsson H: Immunity during cyclosporine therapy. J Am Acad Dermatol 1990;23: 1294-1300.
4. Penn I: Cancers following cyclosporine therapy. Transplantation 1987;43:32-35.
5. Penn I: The changing pattern of posttransplant malignancies. Transplant Proc 1991;23: 1101-1103.
6. Olshan AF, Mattison DR, Zwanenburg TSB: Cyclosporine A: Review of genotoxicity and potential for adverse human reproductive and developmental effects. Mutat Res 1994;317: 163-173.
7. Opelz G, Henderson R: Incidence of nonHodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993;342:1514-1516.
8. Hiesse C, Kriaa F, Rieu P, Larue JR, Benoît G, Bellamy J, Blanchet P, Charpentier B: Incidence and type of malignancies occurring after renal transplantation in conventionally and cyclosporine-treated recipients: Analysis of a 20-year period in 1,600 patients. Transplant Proc 1995:27:972-974.
9. Gruber SA, Gillingham K, Sothern RB, Stephanian E, Matas AJ, Dünn DL: De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients. Clin Transplant 1994;8:388-395.
10. Arellano F, Krupp PF: Cutaneous malignant melanoma occurring after cyclosporin A therapy. BrJDermatoI 199I;124:611.
11. Bordes-Aznar J, Mancilla E, Rosenblum M, Gabilondo F, Orozco R, Angeles A, Alberu J: Malignant neoplasms in renal transplant patients: A 24-year experience. Transplant Proc 1992:24:1802-1803.
12. Penn I: Cancers in cyclosporine-treated vs azathioprine-treated patients. Transplant Proc 1996:28:876-878.
13. Ryffel B: The carcinogenicity of cyclosporin. Toxicology 1992;73:l-22.
14. Krupp P, Monka C: Side-effect profile of cyclosporin A in patients treated for psoriasis. Br J Dermatol 1990;122(suppl 36):47-56.
15. Powles AV, Baker BS, Valdimarsson H, Hulme B, Fry L: Four years of experience with cyclosporine A for psoriasis. Br J Dermatol 1990; 122(suppl36):12-19.
16. Fradin MS, Ellis C, Voorhees J: Management of patients and side-effects during cyclosporine therapy for cutaneous disorders. J Am Acad Dermatol 1990;23:1265-1275.
17. Griffiths CEM, Powles AV, McFadden J, Baker BS, Valdimarsson H, Fry L: Long-term cyclosporin for psoriasis. Br J Dermatol 1989; 120: 253-260.
18. Berth-Jones J, Graham-Brown RAC, Marks R, Camp RDR, English JSC, Freeman K, Holden CA, Rogers SF, Oliwiecki S, Friedmann PS, Lewis-Jones MS, Archer CB, Adriaans B, Douglas WS, Alien BR: Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis. Br J Dermatol 1997; 136:76-81.
19. Mrowietz U, Farber L, Henneicke-von Zepelin HH, Bachmann H, Welzel D, Christophers E: Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: Results of a multicenter study. J Am AcadDermatol 1995;33:470-475.
20. Grossman R, Chevret S, Abi-Rached J, Blanchet F, Dubertret L: Long-term safety of cyclosporine in the treatment of psoriasis. Arch Dermatol 1996; 132:623-629.
21. Büyükpamukcu N, Karakayali H, Bilgin N: Tumors after renal transplantation. Transplant Proc 1996;28:2317-2318.
22. Stewart T, Tsai J, Grayson H, Henderson R, Opelz G: Incidence of de novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet 1995;346: 796-798.
23. Cardon SB, Larson DF, Rüssel DH: Rapid elevation of rat serum prolactin concentration by cyclosporine, a novel immunosuppressive drug. Biochem Biophys Res Commun 1984; 120:614.
24. Ratajczak T, Mark PJ, Martin RL, Minchin RF: Cyclosporin A potentiates estradiol-induced expression of the cathepsin D gene in MCF7 breast cancer cells. Biochem Biophys Res Commun 1996;220:208-212.
25. Klein JS, Goldin H, Keegan C, Shiomoto G, Israël S, Bronson DM: Clear-cell carcinoma of the lung in a patient treated with cyclosporine for epidermolysis bullosa acquisita. J Am Acad Dermatol 1991;24:297.
26. Bologna C, Picot MC, Jorgensen C, Viu P, Verdier R, Sany J: Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate. Ann Rheum Dis 1997;56: 97-102.